Category: Medical
Group Action Lawyers investigating NHS Breast Cancer Screening Scandal
The Group Action Lawyers are investigating the NHS Breast Cancer Screening Scandal which has broken in the news this week.
Our Group Action Lawyers say there may be legal cases to answer for as Health Secretary, Jeremy Hunt, confirms that 270 women may have died as a direct result of an IT glitch that lead to them NOT receiving vital and potentially life-saving letters inviting them for periodic breast cancer screening.
It’s thought that women aged between 68 and 71 are affected by the glitch that occurred in 2009 that was discovered by Public Health England in January this year.
Continue Reading…
Xarelto side-effects when mixed with other drugs
The issue of Xarelto side-effects when mixed with other drugs is currently being considered as part of the ongoing court action for negligence claims against the manufacturers of Xarelto who allegedly failed to warn users of dangerous side-effects related to use of the drug.
The blood-thinning, anti-stroke drug Xarelto – also sold under the name Rivaroxaban – has been linked to internal bleeding, and negligence claims against the manufacturers are over whether they knew of the risks of internal bleeding associated with the product but failed to warn anyone.
Our Group Action Lawyers have taken on cases to investigate claims here in the UK.
Continue Reading…
Resuscitation system recall issued after risk of damage to lungs found
An error with a resuscitation system has been reported to risk damage to lungs, according to information released by the Medicines and Healthcare Products Regulatory Agency (MHRA).
Manufactured by Intersurgical, the manual resuscitation system – named as the “Bag valve mask” (BVM) – risks damage to lungs due to the potential for excess pressure being delivered by the system.
Given that the defect is with a resuscitation system, this recall is an important one as lives may be at risk as a result of it.
Continue Reading…
Cancer drug recall confirmed by UK regulators
A cancer drug recall has been initiated due to reports of excessive levels of an active ingredient used in the drug.
Pharmaceutical company AstraZeneca UK has initiated the recall, primarily for batch NG327, because the “level of olaparib polymorphic form L exceeds the registered specification limit”.
As well as the batch being recalled above, there are other batches that are a part of the recall as well, which is all said to be a part of a precautionary measure.
Continue Reading…
Risks of infection for patients where Zimmer Biomet hip and trauma instruments are used
Zimmer Biomet have been in the news in recent years over knee replacement device problems, which is one of many stories where medical manufacturers have been in the spotlight for medical device compensation claims.
You only need to look at the massive Metal-on-Metal hip implant cases to see just how big these kinds of claims are.
In this latest story, Zimmer Biomet are recalling specific hip and trauma instruments over potential risks of infections to patients.
Continue Reading…
MHRA announce recall of rectal / pharyngeal temperature sensors
Rectal / pharyngeal (orally inserted) temperature sensors manufactured by Teleflex are a part of a recent recall published by the Medicines and Healthcare Regulatory Authority (MHRA).
The issue with the devices may lead to a misdiagnosis where an inaccurate temperature reading is noted by a medical professional.
With body temperatures often being pivotal to medical diagnosis, this recall is a serious one where patients may be at risk of incorrect advice and treatment off the back of inaccurate temperature readings.
Continue Reading…
Lab error leads to thousands of cervical screening tests being reviewed
A laboratory run by Pathology First, working on behalf of Basildon and Thurrock NHS Foundation Trust, are having to redo thousands of cervical screening tests for cancer after an error was discovered.
The samples affected, which were taken between April 2016 and September 2017 for women aged between 24 and 29 who had smear tests, as well as a number of women in their 60’s, are being re-screened independently.
The results held by the lab were classed as negative, but having had some 2,500 samples re-screened, 17 women have reportedly been invited for further assessments.
Continue Reading…
Aquilon nebulisers – CE mark withdrawn and supply ceased, but many have remained on the market
Despite withdrawal of the CE safety marking for Aquilon series of nebulisers, manufactured by AFP Medical, the nebulisers have still been placed on the market. A number of devices may have been sold despite the withdrawal of the CE marking, which means the safety of the product cannot be guaranteed.
CE safety certification is vital for consumer and supplier confidence in a product, and when it comes to medical products, such approval – or withdrawal, as is the case here – can be even more important.
Continue Reading…
UK government investigating the scale of harm caused by vaginal mesh implants
Our legal team have been assisting people in various situations involving harm caused by vaginal mesh implants.
The UK government review update is welcome news.
Years after the UK’s Medicines & Healthcare products Regulatory Agency (MHRA) investigated issues and decided against recalls and bans, the National Institute for Health and Clinical Excellence (NICE) has suggested the surgery should be banned, and New Zealand have become the first country in the world to put an outright ban in place.
Continue Reading…
Birth defects reportedly caused by in-utero exposure to Epilepsy Drug
A drug that helps control epileptic seizures has been reportedly linked to birth defects and should not be used by pregnant women or women of child-bearing potential.
Depakote was created by French pharmaceutical drug company Sanofi back in 1967. The British equivalent, Epilim, has been available since 1973.
The drug has been used around the world and has gained regulatory approval for treatment of epilepsy, with variations of the drug introduced in 1995 for bipolar manic episodes, and in 1996 to prevent migraines. But, a generation later, it has been revealed the drug can cause severe birth defects at a significantly high percentage.
Continue Reading…